|
| |
Articles
1-56 out of 56 article(s)
| Title |
Author |
Type |
Date |
Words |
| 49. Improvement of the palliative supportive care in pancreatic carcinoma patients with a fermented mistletoe (Viscum album L.) extract treatment. |
Matthes, H.; Friedel, W.E.; Hanisch, J.; Karasmann, M.; Bock, P.R. |
|
Oct 1, 2007 |
458 |
| 48. Validation of a new scale on internal coherence (ICS) with mistletoe-sensitive questions for cancer patients. |
Kroz, M.; Humbroich, K.; Brauer, D.; Zerm, R.; Kirchhoff, M.; Reif, M.; von Laue, H.B.; Schad, F.; N |
|
Oct 1, 2007 |
489 |
| 44. Long-lasting cytotoxic effects of a single application of aqueous extracts from dried Viscum album L. on bladder cancer cells in an in vitro system. |
Simoes-Wust, A.P.; Hunziker-Basler, N.; Zuzak, T.J.; Eggenschwiler, J.; Rist, L.; Viviani, A. |
|
Oct 1, 2007 |
396 |
| 45. Immuno-PCR--highly sensitive protein detection: results of the detection of native mistletoe lectin in human serum samples. |
Adler, M.; Eisenbraun, J. |
|
Oct 1, 2007 |
313 |
| 46. Decrease of in vitro susceptibility of B-CLL cells of patients treated with Viscum album extract towards the applied extract. |
Bussing, A.; Kochskamper, H.; Rieger, S.; Schierholz, J.M.; Schlodder, D. |
|
Oct 1, 2007 |
525 |
| 47. Willingness for the participation in a randomized study on mistletoe treatment: results of a survey including 191 patients from a German university women's hospital. |
Glenz, A.; Kuehn, J.J.; Schneeweiss, A.; Sohn, C.; Strowitzki, T.; Hagens, C.V. |
|
Oct 1, 2007 |
354 |
| 35. Effect of a perioperative infusion of mistletoe extract on surgery-induced immunosuppression in colorectal cancer patients. |
Schink, M.; Troger, W.; Dabidian, A.; Goyert, A.; Scheuerecker, H.; Meyer, J.; Fischer, I.U.; Glaser |
|
Oct 1, 2007 |
424 |
| 37. Comparison of survival time in patients with different tumour entities: retrospective efficacy investigations of mistletoe therapy vs. data of a tumour registry. |
Stumpf, C.; Rieger, S.; Fischer, I.U.; Schierholz, J.; Schietzel, M. |
|
Oct 1, 2007 |
365 |
| 38. Treatment with a fermented mistletoe (Viscum album L.) extract as part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma. |
Bock, P.R.; Hanisch, J.; Friedel, W.E.; Matthes, H. |
|
Oct 1, 2007 |
484 |
| 39. Randomized and non-randomized controlled cohort studies for the prevention of cancer with a mistletoe extract for myomas, endometrioses and cervix dysplasia. |
Ziegler, R.; Grossarth-Maticek, R. |
|
Oct 1, 2007 |
354 |
| 40. Self-cleavage of mistletoe lectin I into the A and B subunits by thiol-disulfide exchange reaction. |
Pfuller, U.; Pfuller, Karola |
|
Oct 1, 2007 |
356 |
| 41. Interaction of lectin from Viscum album L. with arabinogalactan-proteins from Echinacea purpurea L. Moench. |
Classen, B.; Herbst, B.; Blaschek, W.; Pfuller, K.; Pfuller, U. |
|
Oct 1, 2007 |
395 |
| 42. Characterisation and quantification of polysaccharides in extracts from Viscum album L. with CE-UV. |
Jager, S.; Beffert, M.; Hoppe, K.; Scheffler, A. |
Brief article |
Oct 1, 2007 |
208 |
| 43. Interactions of viscotoxins with vesicles of genuine membranes of mistletoe. |
Winkler, K.; Jager, S.; Leneweit, G.; Schubert, R. |
Brief article |
Oct 1, 2007 |
219 |
| 18. Inhibitory effects of solubilized triterpene acids from Viscum album L. on murine and human skin cell lines. |
Struh, C.M.; Jager, S.; Schempp, C.M.; Scheffler, A.; Martin, S.F. |
Brief article |
Oct 1, 2007 |
277 |
| 19. Absence of tumour growth stimulation and cytotoxic activity of standardized mistletoe extracts in human tumour cell lines in vitro. |
Kelter, G.; Fischer, I.U.; Fiebig, H.H. |
|
Oct 1, 2007 |
366 |
| 20. The effect of Viscum album extract and Vincristine on the proliferation in several multiple myeloma cell lines: the function of IL-6 and IL-10 in the proliferation. |
Kovacs, E.; Link, S.; Toffol-Schmidt, U. |
Brief article |
Oct 1, 2007 |
287 |
| 21. Efficacy and risk estimation of subcutaneous mistletoe treatment (Viscum album L. Pini) in patients with non-Hodgkin's lymphoma. |
Kuehn, J.J. |
|
Oct 1, 2007 |
297 |
| 22. Observation study on treatment with standardized Viscum album extracts (VA-E) in lymphocytic non-Hodgkin lymphoma (CLL): safety and course. |
Gutsch, J.; Rieger, S.; Schierholz, J.M.; Schlodder, D. |
|
Oct 1, 2007 |
486 |
| 23. Efficacy and safety of pulmonary sarcoidosis treatment with Viscum album L.: a case control analysis. |
Grah, C. |
|
Oct 1, 2007 |
407 |
| 24. Induction of apoptosis in exophytic tumour tissue and mediastinal lymph node metastases through intralesional Viscum instillation in bronchial carcinoma. |
Grah, C.; Matthes, B.; Griff, S.; Szymanski, S.; Mairinger, T. |
|
Oct 1, 2007 |
374 |
| 25. The importance of the primary dosis in mistletoe therapy. |
Orange, M.; Lace, A.; von Laue, H.B. |
|
Oct 1, 2007 |
315 |
| 26. Pharmacokinetics of mistletoe lectins--a phase I study. |
Huber, R.; Eisenbraun, J.; Miletzki, B.; Adler, M.; Gleiter, C.H. |
|
Oct 1, 2007 |
329 |
| 27. The use of mistletoe preparations in paediatric oncology--epidemiology and actual practice. |
Langler, A.; Seifert, G.; Tautz, Ch. |
|
Oct 1, 2007 |
314 |
| 28. Treatment with mistletoe extract in patients with breast cancer, a feasibility study to identify surrogate parameters for further studies--design and first results: recruitment, compatibility and safety. |
Hagens, C.V.; Staudt, A.; Glenz, A.; Reinhard-Hennch, B.; Loewe-Mesch, A.; Lewicka, S.; Giese, T.; S |
|
Oct 1, 2007 |
408 |
| 29. Reliability, validity and mistletoe sensitivity of the German version of the cancer fatigue scale (CFS-D). |
Kroz, M.; Reif, M.; von Laue, H.B.; Brauer, D.; Kirchhof, M.; Zerm, R.; Nickel, E.; Riess, H.; Herbs |
|
Oct 1, 2007 |
489 |
| 31. Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe-extract of the apple tree. |
Eisenbraun, J.; Huber, R.; Kroz, M.; Schad, F.; Scheer, R. |
|
Oct 1, 2007 |
423 |
| 32. Additional therapy with mistletoe extracts in breast cancer patients receiving chemotherapy. A prospective randomized open label pilot study. |
Troger, Wilfried |
|
Oct 1, 2007 |
376 |
| 33. Viscum album extract application and the correlation between quality of life and lymphocyte subpopulations in tumour patients. |
Bussing, A.; Troger, W. |
|
Oct 1, 2007 |
654 |
| 34. Safety and efficacy of treatment of breast cancer patients with standardized mistletoe extract: a controlled multicenter comparative cohort study. |
Beuth, J.; Schierholz, J.; Schneider, B. |
|
Oct 1, 2007 |
330 |
| Editorial. |
Scheer, Rainer |
|
Oct 1, 2007 |
1109 |
| 1. Advances in structure elucidation of mistletoe constituents. |
Kreis, Wolfgang |
Brief article |
Oct 1, 2007 |
221 |
| 2. Effects of mistletoe extracts on immunocompetent cells in vitro and in vivo. |
Klein, Reinhild |
|
Oct 1, 2007 |
346 |
| 3. Regulatory options for Viscum album preparations. |
Kirchner, C.; Werner, C.; Knoss, W. |
|
Oct 1, 2007 |
346 |
| 4. What rank has anthroposophic mistletoe therapy in modern multi-modal oncological therapy concepts? A position assessment under clinical aspects. |
Muller-Hubenthal, B.; Weinandy, A.; Kiviet, C. |
Brief article |
Oct 1, 2007 |
272 |
| 5. Significance of lectin-standardized mistletoe therapy in oncology--a tool for the management of adverse effects. |
Holzhauer, P. |
|
Oct 1, 2007 |
286 |
| 7. Systematic reviews on mistletoe in cancer--what implications for future research can be drawn? |
Kienle, G.S.; Kiene, H. |
Brief article |
Oct 1, 2007 |
199 |
| 8. Evidence-based medicine (EbM) versus health services research: how is complementary oncology represented therein? |
Matthes, H. |
|
Oct 1, 2007 |
431 |
| 9. Influence of soil chemical factors on the cultivation of oak mistletoe (Viscum album on Quercus robur and petraea) and host-specific mineral concentrations of mistletoe extracts. |
Ramm, H. |
|
Oct 1, 2007 |
357 |
| 10. Biochemistry and molecular biology of mistletoe--host tree interaction and specificity. |
Stoll, G. |
Brief article |
Oct 1, 2007 |
260 |
| 11. Chronobiological phenomena and seasonal changes in jasmonate levels during the course of the year and under constant conditions in mistletoe (Viscum album L.). |
Dorka, R.; Miersch, O.; Wasternack, C.; Weik, P. |
|
Oct 1, 2007 |
361 |
| 12. Viscotoxin and mistletoe lectin contents in Viscum album L.--pharmaceutical implications. |
Urech, K.; Jaggy, C.; Schaller, G. |
|
Oct 1, 2007 |
395 |
| 13. Glycan motifs of mistletoe lectins of RIP II type and biological relevance. |
Pfuller, U.; Pfuller, K.; Wahlkamp, M. |
|
Oct 1, 2007 |
413 |
| 14. Characterization of arabinogalactan-proteins from Viscum album L. berries and herb. |
Herbst, B.; Classen, B.; Blaschek, W. |
|
Oct 1, 2007 |
417 |
| 15. Formation of colloidal structures during drop impact in a pharmaceutical flow process. |
Vranceanu, M.; Winkler, K.; Koehler, R.; Leneweit, G. |
|
Oct 1, 2007 |
425 |
| 16. Specific targeting of liposomes functionalized with mistletoe lectin I. |
Bunjes, V.; Winkler, K.; Peschka-Suss, R.; Schubert, R. |
Brief article |
Oct 1, 2007 |
280 |
| 17. Aqueous mistletoe preparations with a high content of oleanolic acid and betulinic acid. |
Jager, S.; Beffert, M.; Hoppe, K.; Scheffler, A. |
|
Oct 1, 2007 |
362 |
| Perilous plants. |
|
Brief article |
Nov 1, 2006 |
122 |
| Skeeter slayer: an award-winning teen uses charts and graphs to search for a natural mosquito killer. |
Norlander, Britt |
Cover Story |
Sep 19, 2005 |
862 |
| From bad to benefactor. (Clippings). |
Stewart, Melissa |
|
Mar 22, 2003 |
363 |
| Mistletoe, of all things, helps juniper trees. (Science News of the week). |
Milius, S. |
Brief Article |
Jan 5, 2002 |
489 |
| Kissing cancer away: the effect of Phoradendron serotinum from Acer pseudoplatanus Loranthceae as a cure for breast cancer. |
Greene, Dekera M. |
Brief Article |
Jan 1, 2002 |
287 |
| Botany under the Mistletoe. |
MILIUS, SUSAN |
|
Dec 23, 2000 |
2252 |
| Nightlife: Marsupial meets mistletoe. |
S.M. |
Brief Article |
Dec 23, 2000 |
178 |
| Bee-friendly mistletoe gets needed help. |
Raloff, Janet |
Brief Article |
Dec 21, 1996 |
533 |
| Mistletoe magic. |
Hearn, Brian |
|
Dec 1, 1996 |
366 |
|
